Ranking · Unmet Need

Trial Gap Index

Burden percentile minus active-trial percentile within the same scope. Positive values flag cancers with high mortality burden but comparatively few active trials. A quantitative signal, not an accusation (CLAUDE.md §324). Caveat (Phase 1): trial counts aggregate a cancer and its NCIt descendants only; registrations phrased at a broader level (e.g. "colorectal cancer" for colon and rectal cancer) are attributed to the broader entity, which can overstate the gap of narrower top-level sites.

Computedci-trial-gap-v1unit: percentile pointshigher = worseAll metrics

Rank	Δ	Cancer	Trial Gap Index (percentile points)	Percentile	Confidence	Sources	Why #n?
1	▲1	Malignant Colon Neoplasm	+51.9	100	Medium confidence	cdc-uscs clinicaltrials cdc-wonder seer iarc-globocan	inputs deaths 19641 formula percentile(mortality_count) − percentile(active_trials) activity 225 burdenPercentile 88.9 activityPercentile 37 ranking row 2609129
2	▲1	Malignant Vulvar Neoplasm	+25.9	96.3	Medium confidence	cdc-uscs clinicaltrials cdc-wonder seer iarc-globocan	inputs deaths 1555 formula percentile(mortality_count) − percentile(active_trials) activity 54 burdenPercentile 33.3 activityPercentile 7.4 ranking row 2609130
3	▲2	Malignant Uterine Corpus Neoplasm	+22.2	92.6	Medium confidence	cdc-uscs clinicaltrials cdc-wonder seer iarc-globocan	inputs deaths 8608 formula percentile(mortality_count) − percentile(active_trials) activity 411 burdenPercentile 74.1 activityPercentile 51.9 ranking row 2609131
4	▲3	Malignant Rectal Neoplasm	+14.9	88.9	Medium confidence	cdc-uscs clinicaltrials cdc-wonder seer iarc-globocan	inputs deaths 5399 formula percentile(mortality_count) − percentile(active_trials) activity 386 burdenPercentile 63 activityPercentile 48.1 ranking row 2609132
5	▼1	Cutaneous Melanoma	+14.8	85.2	Medium confidence	cdc-uscs clinicaltrials cdc-wonder seer iarc-globocan	inputs deaths 3073 formula percentile(mortality_count) − percentile(active_trials) activity 78 burdenPercentile 37 activityPercentile 22.2 ranking row 2609133
5	=	Malignant Vaginal Neoplasm	+14.8	85.2	Medium confidence	cdc-uscs clinicaltrials cdc-wonder seer iarc-globocan	inputs deaths 435 formula percentile(mortality_count) − percentile(active_trials) activity 31 burdenPercentile 14.8 activityPercentile 0 ranking row 2609134
7	▲1	Malignant Ovarian Neoplasm	+14.8	77.8	Medium confidence	cdc-uscs clinicaltrials cdc-wonder seer iarc-globocan	inputs deaths 12654 formula percentile(mortality_count) − percentile(active_trials) activity 684 burdenPercentile 85.2 activityPercentile 70.4 ranking row 2609135
8	▲1	Malignant Pancreatic Neoplasm	+11.1	74.1	Medium confidence	cdc-uscs clinicaltrials cdc-wonder seer iarc-globocan	inputs deaths 24721 formula percentile(mortality_count) − percentile(active_trials) activity 904 burdenPercentile 92.6 activityPercentile 81.5 ranking row 2609136
9	▲1	Malignant Bladder Neoplasm	+7.5	70.4	Medium confidence	cdc-uscs clinicaltrials cdc-wonder seer iarc-globocan	inputs deaths 4761 formula percentile(mortality_count) − percentile(active_trials) activity 346 burdenPercentile 51.9 activityPercentile 44.4 ranking row 2609137
10	▲3	Malignant Anal Neoplasm	+7.4	66.7	Medium confidence	cdc-uscs clinicaltrials cdc-wonder seer iarc-globocan	inputs deaths 1067 formula percentile(mortality_count) − percentile(active_trials) activity 68 burdenPercentile 25.9 activityPercentile 18.5 ranking row 2609139
10	▲4	Malignant Laryngeal Neoplasm	+7.4	66.7	Medium confidence	cdc-uscs clinicaltrials cdc-wonder seer iarc-globocan	inputs deaths 826 formula percentile(mortality_count) − percentile(active_trials) activity 66 burdenPercentile 22.2 activityPercentile 14.8 ranking row 2609138
12	▲4	Malignant Kidney Neoplasm	+3.7	59.3	Medium confidence	cdc-uscs clinicaltrials cdc-wonder seer iarc-globocan	inputs deaths 5078 formula percentile(mortality_count) − percentile(active_trials) activity 453 burdenPercentile 59.3 activityPercentile 55.6 ranking row 2609140
13	▲4	Malignant Breast Neoplasm	0	55.6	Medium confidence	cdc-uscs clinicaltrials cdc-wonder seer iarc-globocan	inputs deaths 43402 formula percentile(mortality_count) − percentile(active_trials) activity 2627 burdenPercentile 96.3 activityPercentile 96.3 ranking row 2609141
13	▲4	Malignant Lung Neoplasm	0	55.6	Medium confidence	cdc-uscs clinicaltrials cdc-wonder seer iarc-globocan	inputs deaths 61626 formula percentile(mortality_count) − percentile(active_trials) activity 2644 burdenPercentile 100 activityPercentile 100 ranking row 2609142
13	▲4	Malignant Salivary Gland Neoplasm	0	55.6	Medium confidence	cdc-uscs clinicaltrials cdc-wonder seer iarc-globocan	inputs deaths 391 formula percentile(mortality_count) − percentile(active_trials) activity 63 burdenPercentile 11.1 activityPercentile 11.1 ranking row 2609143
13	▲13	Malignant Thyroid Gland Neoplasm	0	55.6	Medium confidence	cdc-uscs clinicaltrials cdc-wonder seer iarc-globocan	inputs deaths 1181 formula percentile(mortality_count) − percentile(active_trials) activity 176 burdenPercentile 29.6 activityPercentile 29.6 ranking row 2609144
17	▲4	Malignant Hypopharyngeal Neoplasm	-3.7	40.7	Medium confidence	cdc-uscs clinicaltrials cdc-wonder seer iarc-globocan	inputs deaths 105 formula percentile(mortality_count) − percentile(active_trials) activity 53 burdenPercentile 0 activityPercentile 3.7 ranking row 2609145
18	▼1	Malignant Liver Neoplasm	-3.7	37	Medium confidence	cdc-uscs clinicaltrials cdc-wonder seer iarc-globocan	inputs deaths 10877 formula percentile(mortality_count) − percentile(active_trials) activity 906 burdenPercentile 81.5 activityPercentile 85.2 ranking row 2609146
19	▲3	Malignant Mesothelioma	-7.4	33.3	Medium confidence	cdc-uscs clinicaltrials cdc-wonder seer iarc-globocan	inputs deaths 574 formula percentile(mortality_count) − percentile(active_trials) activity 96 burdenPercentile 18.5 activityPercentile 25.9 ranking row 2609147
20	▲5	Malignant Central Nervous System Neoplasm	-11.1	29.6	Medium confidence	cdc-uscs clinicaltrials cdc-wonder seer iarc-globocan	inputs deaths 8120 formula percentile(mortality_count) − percentile(active_trials) activity 823 burdenPercentile 66.7 activityPercentile 77.8 ranking row 2609148
21	▲6	Leukemia	-11.1	25.9	Medium confidence	cdc-uscs clinicaltrials cdc-wonder seer iarc-globocan	inputs deaths 9951 formula percentile(mortality_count) − percentile(active_trials) activity 1769 burdenPercentile 77.8 activityPercentile 88.9 ranking row 2609149
22	▲8	Malignant Cervical Neoplasm	-14.9	22.2	Medium confidence	cdc-uscs clinicaltrials cdc-wonder seer iarc-globocan	inputs deaths 4207 formula percentile(mortality_count) − percentile(active_trials) activity 505 burdenPercentile 44.4 activityPercentile 59.3 ranking row 2609150
23	▲4	Multiple Myeloma	-18.5	18.5	Medium confidence	cdc-uscs clinicaltrials cdc-wonder seer iarc-globocan	inputs deaths 4981 formula percentile(mortality_count) − percentile(active_trials) activity 814 burdenPercentile 55.6 activityPercentile 74.1 ranking row 2609151
24	▲7	Malignant Gastric Neoplasm	-18.6	14.8	Medium confidence	cdc-uscs clinicaltrials cdc-wonder seer iarc-globocan	inputs deaths 4361 formula percentile(mortality_count) − percentile(active_trials) activity 652 burdenPercentile 48.1 activityPercentile 66.7 ranking row 2609152
25	▲8	Non-Hodgkin Lymphoma	-22.2	11.1	Medium confidence	cdc-uscs clinicaltrials cdc-wonder seer iarc-globocan	inputs deaths 8366 formula percentile(mortality_count) − percentile(active_trials) activity 2168 burdenPercentile 70.4 activityPercentile 92.6 ranking row 2609153
26	▲6	Malignant Esophageal Neoplasm	-22.3	7.4	Medium confidence	cdc-uscs clinicaltrials cdc-wonder seer iarc-globocan	inputs deaths 3298 formula percentile(mortality_count) − percentile(active_trials) activity 518 burdenPercentile 40.7 activityPercentile 63 ranking row 2609154
27	▲7	Hodgkin Lymphoma	-25.9	3.7	Medium confidence	cdc-uscs clinicaltrials cdc-wonder seer iarc-globocan	inputs deaths 358 formula percentile(mortality_count) − percentile(active_trials) activity 179 burdenPercentile 7.4 activityPercentile 33.3 ranking row 2609155
28	▲7	Malignant Nasopharyngeal Neoplasm	-37	0	Medium confidence	cdc-uscs clinicaltrials cdc-wonder seer iarc-globocan	inputs deaths 205 formula percentile(mortality_count) − percentile(active_trials) activity 261 burdenPercentile 3.7 activityPercentile 40.7 ranking row 2609156

Data updated 16 hours agoSource updated unknown28 eligible entities · inputs hash 8bb8392360b97a549e3a1451

Methodology

How this table was built

Formula: percentile(mortality_count) − percentile(active_trials)
Version: ci-trial-gap-v1
Scope: USA · Female · all ages · 2024 · top-level cancers
Scope key: geo=USA|sex=female|age=all|year=2024|level=top
Eligible entities: 28
Generated: Sep 29, 2026, 06:30 AM UTC
Inputs hash: 8bb8392360b97a549e3a1451
Sources: U.S. Cancer Statistics (USCS) — NPCR/SEER incidence and NVSS mortality clinicaltrials cdc-wonder seer iarc-globocan
Aggregation: none

Eligibility

requires: mortality_count
active_trials
entityLevel: top

Full methodology · ties share a rank (1, 2, 2, 4) · previous rank refers to the last snapshot of the same scope.

Download CSV (with attribution)

Burden and lethality metrics depend on registry definitions (site groups, standard population, estimate type). Compare only within one table.